Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10123444 | British Journal of Anaesthesia | 2005 | 6 Pages |
Abstract
At the bolus dose used remifentanil PCA has an acceptable level of maternal side-effects and minimal effect on the neonate. Remifentanil crosses the placenta and appears to be either rapidly metabolized or redistributed in the neonate.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
I. Volikas, A. Butwick, C. Wilkinson, A. Pleming, G. Nicholson,